FISCAL YEAR 2012 FINANCIAL STATEMENTS

Tamaño: px
Comenzar la demostración a partir de la página:

Download "FISCAL YEAR 2012 FINANCIAL STATEMENTS"

Transcripción

1 FINANCIAL STATEMENTS APRIL 2012 FINANCIAL SERVICES

2 TABLE OF TENTS 2 Balanced Scorecard Comparison...3 Executive Summary of Key Indicators...4 Key Variance MTD & YTD...5 Balance Sheet...8 Income Statement Month-to-Date...10 Year-to-Date...11 Current vs. Prior Year-to-Date...12 Fiscal Year Projection...13 Monthly Trend...14 Cash Flow Statement Consolidated...15 Financial Report Narrative...16 Key Statistical Indicators...19 Year-to-Date Supplies Expense by Account...22 Bond Covenant Ratios...23 Budget Comparison Graphs Statistical Indicators...24 Payor Mix...41 Case Mix Index Graphs...42 Budget Comparison Graphs Adjusted Discharges...45 Cash Collections...51 HealthWoRx Dashboard...52 Supplemental Information Flash Report...54

3 BALANCED SCORECARD COMPARISON 3 January February March April YTD 2012 Actual Actual Actual Actual Budget Variance %Actual to Budget Actual Budget Variance PPH Indicators: %Actual to Budget 8.62% 8.41% 8.93% 5.89% 9.35% (3.46%) 63.0% OEBITDA Margin w/prop Tax 9.39% 10.39% (1.00%) 90.4% $ 12, $ 12, $ 12, $ 13, $ 12, $ (917.30) 107.5% Expenses/Adj Discharge $ 12, $ 12, $ (347.30) 102.9% $ 7, $ 7, $ 7, $ 8, $ 7, $ (922.47) 112.4% SWB/Adj Discharge $ 7, $ 7, $ (359.53) 104.9% (0.39) 105.9% Prod FTE's/Adj Occupied Bed (0.05) 100.8% 3,363 3,259 3,572 3,176 3,400 (224) 93.4% Adjusted Discharges 33,532 34,562 (1,030) 97.0% PPH North Indicators: 7.70% 10.25% 7.09% 0.46% 9.19% (8.73%) 5.0% OEBITDA Margin w/prop Tax 9.04% 10.27% (1.23%) 88.0% $ 11, $ 11, $ 11, $ 12, $ 11, $ (689.09) 106.0% Expenses/Adj Discharge $ 11, $ 11, $ (326.65) 102.9% $ 6, $ 6, $ 6, $ 6, $ 5, $ (703.26) 111.8% SWB/Adj Discharge $ 6, $ 5, $ (387.08) 106.6% (0.33) 106.2% Prod FTE's/Adj Occupied Bed (0.10) 101.9% 2,397 2,382 2,547 2,298 2,428 (130) 94.6% Adjusted Discharges 24,068 24,668 (600) 97.6% PPH South Indicators: 8.70% (0.36%) 11.66% 14.55% 6.65% 7.90% % OEBITDA Margin w/prop Tax 8.03% 7.68% 0.35% 104.6% $ 13, $ 13, $ 12, $ 14, $ 13, $ (933.53) 107.0% Expenses/Adj Discharge $ 13, $ 13, $ (120.22) 100.9% $ 6, $ 7, $ 6, $ 7, $ 6, $ (688.15) 110.2% SWB/Adj Discharge $ 6, $ 6, $ (183.01) 102.8% (0.67) 110.4% Prod FTE's/Adj Occupied Bed (0.30) 104.7% , (91) 90.4% Adjusted Discharges 9,268 9,681 (413) 95.7%

4 EXECUTIVE SUMMARY OF KEY INDICATORS 4 April 2012 FY 12 April 2012 Actual Budget Variance Actual Budget Variance Statistics: Adjusted Discharges 3,176 3,400 (224) 33,532 34,562 (1,030) Acute Admissions 2,008 2,179 (171) 21,447 22,155 (708) Acute Patient Days 7,888 8,440 (552) 84,403 85,805 (1,402) Acute ALOS Acute ADC (18.40) (5.54) Case Mix Index (w/o Births) Total Surgeries 1,508 1,538 (30) 15,108 15,641 (533) Births (54) 3,932 4,171 (239) E/R Visits & Admissions 8,063 8, ,232 81, ER to Admit Rate 14.3% 15.5% (1.2%) 15.2% 15.6% (0.4%) Productivity % 95.1% 100.0% (4.9%) 97.6% 100.0% (2.4%) Moody Benchmark Income Statement: Net Patient Revenue 40,528,986 41,836,495 (1,307,509) 420,740, ,144,818 (4,404,770) Total Net Revenue 41,568,009 42,712,848 (1,144,839) 430,519, ,908,348 (3,388,623) Sal., Wages, Cont. Lbr 20,835,430 19,751,352 (1,084,078) 200,583, ,004,120 (3,579,077) Supplies 6,260,073 5,971,932 (288,141) 62,814,383 60,710,562 (2,103,821) Total Expenses 41,954,159 41,794,313 (159,846) 418,673, ,530, ,067 Net Inc. (Loss) before Non-Op (386,150) 918,535 (1,304,685) 11,845,920 14,377,476 (2,531,556) Net Income (Loss) 954,624 1,887,626 (933,002) 24,116,721 24,068,386 48,335 Cash Flow: Cash Collections 41,600,000 42,000,000 (400,000) 384,100, ,000,000 (35,900,000) Days Cash on Hand Ratios: OEBITDA w/ Prop. Tax 5.89% 9.35% (3.46%) 9.39% 10.39% (1.00%) Net Income Margin 2.30% 4.42% (2.12%) 5.60% 5.55% 0.05% Bad Debt % of Net Patient Revenue 13.6% 12.4% (1.2%) 14.8% 12.4% (2.4%) 7.1% Return On Assets 1.7% 1.7% 0.0% 2.2% Annual Debt Service Coverage Cushion Ratio

5 KEY VARIANCE EXPLANATIONS 5 Actual Budget Month-to Date Variance Detail Variance Actual Budget Year-to Date Variance Detail Variance (386,150) 918,535 (1,304,685) Net Income From Operations 11,845,920 14,377,476 (2,531,556) (1,307,509) Total Net Patient Revenue (4,404,770) (1,307,509) Net Patient Revenue (4,404,770) 162,670 Other Operating Revenue 1,016, ,070 Rebates and Refunds 816,776 (1,400) Other 199,371 (685,753) Salaries & Wages (1,080,985) 1,285,246 Volume Variance 5,797,338 (1,970,999) Rate & Efficiency (6,878,323) (182,247) Benefits (955,926) (147,210) Pension (1,488,172) (35,037) Other 532,246 (398,325) Contract Labor (2,498,092) 16,020 Volume Variance 73,684 (414,345) Rate & Efficiency (2,571,776) 13,311 Professional Fees 571,044 13,311 Professional Fees 571,044

6 KEY VARIANCE EXPLANATIONS 6 Actual Budget Month-to Date Variance Detail Variance Actual Budget Year-to Date Variance Detail Variance (288,141) Supplies (2,103,821) 393,445 Volume Variance 1,809,267 (681,586) Rate & Efficiency (3,913,088) Breakdown of Variance: (149,497) Surgery General (1,183,875) 62,696 Prosthesis (645,251) (201,340) Other (274,695) 339,120 Purchased Services 1,089, ,140 Biomed (108,002) (64,117) Patient Financial Services - contra to revenue (449,369) 141,097 Other 1,646, ,235 Depreciation 2,118, ,235 Depreciation 2,118, ,954 Other Direct Expenses 3,716, ,954 Other Direct 3,716,668 (386,150) 918,535 (1,304,685) Net Income From Operations 11,845,920 14,377,476 (2,531,556)

7 KEY VARIANCE EXPLANATIONS 7 Month-to Date Year-to Date Actual Budget Variance Actual Budget Variance (386,150) 918,535 (1,304,685) Net Income From Operations 11,845,920 14,377,476 (2,531,556) 1,340, , ,683 Non-Operating Income 12,270,801 9,690,910 2,579,891 1,083,333 1,083,334 (1) Property Tax 10,851,017 10,833,340 17, , , ,612 Investment Income (Loss) 2,173,334 2,171,420 1,914 Breakdown: 118,110 58,333 59,777 Pacific Income Advisors 518, ,333 (65,002) 194,707 97,917 96,790 Legg Mason / Clearbridge 960, ,167 (18,189) 11,183 9,417 1,766 LAIF 148,176 94,173 54,003 62,754 51,475 11,279 Other 545, ,747 31, , , ,170 Interest Expense 2,374,780 3,684,150 1,309,370 82,932 37,030 45,902 Other 1,621, ,300 1,250, ,624 1,887,626 (933,002) Net Income 24,116,721 24,068,386 48,335

8 BALANCE SHEET SOLIDATED (INCLUDES G.O. BONDS) 8 Current Prior Prior Fiscal Current Prior Prior Fiscal Month Month Year End Month Month Year End Assets Liabilities Current Assets Current Liabilities Cash on Hand $10,283,816 $6,001,282 $11,960,791 Accounts Payable $25,486,168 $23,292,008 $56,116,169 Cash Marketable Securities 150,823, ,461, ,340,613 Accrued Payroll 12,449,511 13,752,204 13,216,614 Total Cash & Cash Equivalents 161,107, ,462, ,301,404 Accrued PTO 18,099,712 17,892,736 17,284,147 Accrued Interest Payable 16,218,286 13,012,957 9,490,711 Patient Accounts Receivable 266,827, ,727, ,412,396 Current Portion of Bonds 9,311,650 9,311,650 8,366,793 Allowance on Accounts (167,467,748) (183,877,560) (117,860,257) Est Third Party Settlements 3,012,688 3,292,710 3,353,441 Net Accounts Receivable 99,359, ,850,292 79,552,139 Other Current Liabilities 25,477,093 26,100,461 28,049,558 Total Current Liabilities 110,055, ,654, ,877,433 Inventories 7,058,484 7,099,637 7,175,585 Prepaid Expenses 2,616,319 4,839,507 2,742,378 Long Term Liabilities Other 9,390,234 18,196,414 8,014,960 Other LT Liabilities 1,725,356 1,752,948 1,637,734 Total Current Assets 279,531, ,448, ,786,466 Bonds & Contracts Payable 1,130,815,483 1,129,355,187 1,125,514,469 1,132,540,839 1,131,108,135 1,127,152,203 Non-Current Assets Restricted Assets 138,335, ,848, ,559,885 General Fund Balance Restricted by Donor 325, , ,613 Unrestricted 430,723, ,316, ,096,646 Board Designated 9,258,782 9,796,883 0 Restricted for Other Purpose 325, , ,613 Total Restricted Assets 147,920, ,970, ,877,498 Board Designated 9,258,782 9,796,883 0 Total Fund Balance 440,308, ,439, ,414,259 Property Plant & Equipment 427,690, ,258, ,894,261 Accumulated Depreciation (265,533,249) (263,733,235) (251,051,249) Total Liabilities / Fund Balance $1,682,904,418 $1,676,202,117 $1,669,443,895 Construction in Process 1,062,312,116 1,045,198, ,800,710 Net Property Plant & Equipment 1,224,469,239 1,208,723,699 1,061,643,722 Investment in Related Companies 2,758,061 2,791,099 2,884,377 Deferred Financing Costs 23,289,636 23,404,761 24,441,044 Other Non-Current Assets 4,935,649 4,862,920 2,810,788 Total Non-Current Assets 1,403,372,646 1,384,753,377 1,383,657,429 Total Assets $1,682,904,418 $1,676,202,117 $1,669,443,895

9 BALANCE SHEET SOLIDATED (EXCLUDES G.O. BONDS) 9 Current Prior Prior Fiscal Current Prior Prior Fiscal Month Month Year End Month Month Year End Assets Liabilities Current Assets Current Liabilities Cash on Hand $10,283,816 $6,001,282 $11,960,791 Accounts Payable $25,486,168 $23,292,008 $56,116,169 Cash Marketable Securities 150,823, ,461, ,340,613 Accrued Payroll 12,449,511 13,752,204 13,216,614 Total Cash & Cash Equivalents 161,107, ,462, ,301,404 Accrued PTO 18,099,712 17,892,736 17,284,147 Accrued Interest Payable 13,086,454 10,892,011 4,428,990 Patient Accounts Receivable 266,827, ,727, ,412,396 Current Portion of Bonds 7,080,000 7,080,000 6,715,000 Allowance on Accounts (167,467,748) (183,877,560) (117,860,257) Est Third Party Settlements 3,012,688 3,292,710 3,353,441 Net Accounts Receivable 99,359, ,850,292 79,552,139 Other Current Liabilities 25,477,093 26,100,461 28,049,558 Total Current Liabilities 104,691, ,302, ,163,919 Inventories 7,058,484 7,099,637 7,175,585 Prepaid Expenses 2,616,319 4,839,507 2,742,378 Long Term Liabilities Other 10,338,358 16,114,478 7,917,214 Other LT Liabilities 1,725,356 1,752,948 1,637,734 Total Current Assets 280,479, ,366, ,688,720 Bonds & Contracts Payable 593,796, ,740, ,310, ,522, ,493, ,947,868 Non-Current Assets Restricted Assets 123,518, ,311, ,605,560 General Fund Balance Restricted by Donor 325, , ,613 Unrestricted 949,492, ,878, ,793,870 Board Designated 9,258,782 9,796,883 0 Restricted for Other Purpose 325, , ,613 Total Restricted Assets 133,103, ,434, ,923,173 Board Designated 9,258,782 9,796,883 0 Total Fund Balance 959,077, ,001, ,111,483 Property Plant & Equipment 427,690, ,258, ,894,261 Accumulated Depreciation (265,533,249) (263,733,235) (251,051,249) Total Liabilities / Fund Balance $1,659,290,788 $1,653,796,242 $1,644,223,270 Construction in Process 1,062,312,116 1,045,198, ,800,710 Net Property Plant & Equipment 1,224,469,239 1,208,723,699 1,061,643,722 Investment in Related Companies 2,758,061 2,791,099 2,884,377 Deferred Financing Costs 13,544,859 13,617,622 14,272,490 Other Non-Current Assets 4,935,649 4,862,920 2,810,788 Total Non-Current Assets 1,378,810,892 1,364,429,438 1,358,534,550 Total Assets $1,659,290,788 $1,653,796,242 $1,644,223,270

10 INCOME STATEMENT: MONTH-TO-DATE SOLIDATED ADJUSTED DISCHARGES 10 Variance $/Adjusted Discharges Actual Budget Variance Volume Rate/Eff Actual Budget Variance Statistics: Admissions - Acute 2,008 2,179 (171) Admissions - SNF Patient Days - Acute 7,888 8,440 (552) Patient Days - SNF 6,124 6,173 (49) ALOS - Acute ALOS - SNF Adjusted Discharges 3,176 3,400 (224) Revenue: Gross Revenue $ 163,742,001 $ 159,356,038 $ 4,385,963 F $ (10,498,751) $ 14,884,714 $ 51, $ 46, $ 4, Deductions from Rev (123,213,015) (117,519,543) (5,693,472) U 7,742,464 (13,435,936) (38,795.03) (34,564.57) (4,230.46) Net Patient Revenue 40,528,986 41,836,495 (1,307,509) U (2,756,287) 1,448,778 12, , Other Oper Revenue 1,039, , ,670 F (57,736) 220, Total Net Revenue 41,568,009 42,712,848 (1,144,839) U (2,814,023) 1,669,184 13, , Expenses: Salaries, Wages & Contr Labor 20,835,430 19,751,352 (1,084,078) U 1,301,266 (2,385,344) 6, , (751.05) Benefits 5,679,529 5,497,282 (182,247) U 362,174 (544,421) 1, , (171.42) Supplies 6,260,073 5,971,932 (288,141) U 393,445 (681,586) 1, , (214.61) Prof Fees & Purch Svc 5,633,283 5,985, ,431 F 394,353 (41,922) 1, , (13.20) Depreciation 1,750,513 1,991, ,235 F 131, , Other 1,795,331 2,596, ,954 F 171, , Total Expenses 41,954,159 41,794,313 (159,846) U 2,753,508 (2,913,354) 13, , (917.30) Net Inc Before Non-Oper Income (386,150) 918,535 (1,304,685) U (60,515) (1,244,170) (121.58) (391.74) 1 Property Tax Revenue 1,083,333 1,083,334 (1) U (71,373) 71, Non-Operating Income 257,441 (114,243) 371,684 F 7, , (33.60) Net Income (Loss) $ 954,624 $ 1,887,626 $ (933,002) U $ (124,361) $ (808,641) $ $ $ (254.61) Net Income Margin 2.30% 4.42% (2.12%) OEBITDA Margin w/o Prop Tax 3.28% 6.81% (3.53%) OEBITDA Margin with Prop Tax 5.89% 9.35% (3.46%) F= Favorable variance U= Unfavorable variance 1= Property Tax Revenue does not include G.O. Bonds Levy 2= Interest Expense does not include G.O. Bonds Interest

11 INCOME STATEMENT: YEAR-TO-DATE SOLIDATED ADJUSTED DISCHARGES 11 Variance $/Adjusted Discharges Actual Budget Variance Volume Rate/Eff Actual Budget Variance Statistics: Admissions - Acute 21,447 22,155 (708) Admissions - SNF 1, Patient Days - Acute 84,403 85,805 (1,402) Patient Days - SNF 62,206 62,753 (547) ALOS - Acute ALOS - SNF Adjusted Discharges 33,532 34,562 (1,030) Revenue: Gross Revenue $ 1,665,328,959 $ 1,619,897,853 $ 45,431,106 F $ (48,275,412) $ 93,706,518 $ 49, $ 46, $ 2, Deductions from Rev (1,244,588,911) (1,194,753,035) (49,835,876) U 35,605,452 (85,441,328) (37,116.45) (34,568.40) (2,548.05) Net Patient Revenue 420,740, ,144,818 (4,404,770) U (12,669,960) 8,265,190 12, , Other Oper Revenue 9,779,677 8,763,530 1,016,147 F (261,166) 1,277, Total Net Revenue 430,519, ,908,348 (3,388,623) U (12,931,127) 9,542,504 12, , Expenses: Salaries, Wages & Contr Labor 200,583, ,004,120 (3,579,077) U 5,871,021 (9,450,098) 5, , (281.82) Benefits 56,315,148 55,359,222 (955,926) U 1,649,789 (2,605,715) 1, , (77.71) Supplies 62,814,383 60,710,562 (2,103,821) U 1,809,267 (3,913,088) 1, , (116.70) Prof Fees & Purch Svc 58,806,361 60,467,022 1,660,661 F 1,802,009 (141,348) 1, , (4.22) Depreciation 17,746,562 19,865,124 2,118,562 F 592,011 1,526, Other 22,408,154 26,124,822 3,716,668 F 778,559 2,938, Total Expenses 418,673, ,530, ,067 F 12,502,656 (11,645,589) 12, , (347.30) Net Inc Before Non-Oper Income 11,845,920 14,377,476 (2,531,556) U (428,471) (2,103,085) (62.72) 1 Property Tax Revenue 10,851,017 10,833,340 17,677 F (322,850) 340, Non-Operating Income 1,419,784 (1,142,430) 2,562,214 F 34,046 2,528, (33.05) Net Income (Loss) $ 24,116,721 $ 24,068,386 $ 48,335 F $ (717,274) $ 765,609 $ $ $ Net Income Margin 5.60% 5.55% 0.05% OEBITDA Margin w/o Prop Tax 6.87% 7.89% (1.02%) OEBITDA Margin with Prop Tax 9.39% 10.39% (1.00%) F= Favorable variance U= Unfavorable variance 1= Property Tax Revenue does not include G.O. Bonds Levy 2= Interest Expense does not include G.O. Bonds Interest

12 INCOME STATEMENT: CURRENT VS. PRIOR YEAR-TO-DATE SOLIDATED ADJUSTED DISCHARGES Variance 12 $/Adjusted Discharges April 12 YTD April 11 YTD Variance Volume Rate/Eff Actual FY12 Actual FY11 Variance Statistics: Admissions - Acute 21,447 21,935 (488) Admissions - SNF 1, Patient Days - Acute 84,403 86,414 (2,011) Patient Days - SNF 62,206 62,616 (410) ALOS - Acute ALOS - SNF (4.73) Adjusted Discharges 33,532 33,710 (178) Revenue: Gross Revenue $ 1,665,328,959 $ 1,530,240,191 $ 135,088,768 F $ (8,080,177) $ 143,168,945 $ 49, $ 45, $ 4, Deductions from Rev (1,244,588,911) (1,130,709,890) (113,879,021) U 5,970,524 (119,849,545) (37,116.45) (33,542.27) (3,574.18) Net Patient Revenue 420,740, ,530,301 21,209,747 F (2,109,653) 23,319,400 12, , Other Oper Revenue 9,779,677 8,845, ,509 F (46,705) 981, Total Net Revenue 430,519, ,375,469 22,144,256 F (2,156,358) 24,300,614 12, , Expenses: Salaries, Wages & Contr Labor 200,583, ,098,763 (11,484,434) U 998,504 (12,482,938) 5, , (372.27) Benefits 56,315,148 52,620,628 (3,694,520) U 277,854 (3,972,374) 1, , (118.47) Supplies 62,814,383 61,391,686 (1,422,697) U 324,168 (1,746,865) 1, , (52.10) Prof Fees & Purch Svc 58,806,361 53,176,318 (5,630,043) U 280,789 (5,910,832) 1, , (176.27) Depreciation 17,746,562 17,667,803 (78,759) U 93,292 (172,051) (5.13) Other 22,408,154 22,342,554 (65,600) U 117,976 (183,576) (5.47) Total Expenses 418,673, ,297,752 (22,376,053) U 2,092,584 (24,468,637) 12, , (729.71) Net Inc Before Non-Oper Income 11,845,920 12,077,717 (231,797) U (63,774) (168,023) (5.01) 1 Property Tax Revenue 10,851,017 10,683, ,687 F (56,412) 224, Non-Operating Income 2 1,419, ,045 1,166,739 F (1,336) 1,168, Net Income (Loss) $ 24,116,721 $ 23,014,092 $ 1,102,629 F $ (121,522) $ 1,224,151 $ $ $ Net Income Margin 5.60% 5.64% (0.04%) OEBITDA Margin w/o Prop Tax 6.87% 7.28% (0.41%) OEBITDA Margin with Prop Tax 9.39% 9.90% (0.51%) F= Favorable variance U= Unfavorable variance 1= Property Tax Revenue does not include G.O. Bonds Levy 2= Interest Expense does not include G.O. Bonds Interest

13 INCOME STATEMENT: FISCAL YEAR PROJECTION SOLIDATED ADJUSTED DISCHARGES 13 Variance $/Adjusted Discharges 10 Act + 2 Bud FY 12 Budget Variance Volume Rate/Eff Actual Budget Variance Statistics: Admissions - Acute 25,876 26,584 (708) Admissions - SNF 1,239 1, Patient Days - Acute 101, ,961 (1,402) Patient Days - SNF 74,752 75,299 (547) Adjusted Discharges 40,434 41,464 (1,030) Revenue: Gross Revenue $ 1,989,540,594 $ 1,944,109,488 $ 45,431,106 F $ (48,293,285) $ 93,724,391 $ 49, $ 46, $ 2, Deductions from Rev (1,483,692,389) (1,433,856,513) (49,835,876) U 35,618,180 (85,454,056) (36,694.18) (34,580.76) (2,113.42) Net Patient Revenue 505,848, ,252,975 (4,404,770) U (12,675,105) 8,270,335 12, , Other Oper Revenue 11,532,383 10,516,236 1,016,147 F (261,232) 1,277, Total Net Revenue 517,380, ,769,211 (3,388,623) U (12,936,337) 9,547,714 12, , Expenses: Salaries, Wages & Contr Labor 240,801, ,222,454 (3,579,077) U 5,892,802 (9,471,879) 5, , (234.26) Benefits 67,501,107 66,545,182 (955,926) U 1,653,037 (2,608,962) 1, , (64.52) Supplies 74,976,709 72,872,888 (2,103,821) U 1,810,223 (3,914,044) 1, , (96.80) Prof Fees & Purch Svc 70,898,971 72,559,632 1,660,661 F 1,802,441 (141,780) 1, , (3.51) Depreciation 21,730,058 23,848,620 2,118,562 F 592,419 1,526, Other 27,633,118 31,349,786 3,716,668 F 778,755 2,937, Total Expenses 503,541, ,398, ,067 F 12,529,677 (11,672,609) 12, , (288.68) Net Inc Before Non-Oper Income 13,839,094 16,370,649 (2,531,556) U (406,660) (2,124,895) (52.55) 1 Property Tax Revenue 13,017,685 13,000,008 17,677 F (322,931) 340, Non-Operating Income 1,191,298 (1,370,916) 2,562,214 F 34,055 2,528, (33.06) Net Income (Loss) $ 28,048,077 $ 27,999,741 $ 48,335 F $ (695,537) $ 743,873 $ $ $ F= Favorable variance U= Unfavorable variance 1= Property Tax Revenue does not include G.O. Bonds Levy 2= Interest Expense does not include G.O. Bonds Interest

14 INCOME STATEMENT: MONTHLY TREND SOLIDATED ADJUSTED DISCHARGES 14 Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr YTD Statistics: Admissions - Acute 2,121 2,280 2,188 2,096 2,168 2,204 2,131 2,053 2,198 2,008 21,447 Admissions - SNF ,058 Patient Days - Acute 8,197 8,388 8,232 8,619 8,428 8,749 8,866 8,032 9,004 7,888 84,403 Patient Days - SNF 6,174 6,325 6,139 6,288 6,093 6,304 6,357 6,043 6,359 6,124 62,206 ALOS - Acute ALOS - SNF Adjusted Discharges 3,334 3,514 3,399 3,211 3,275 3,428 3,363 3,259 3,572 3,176 33,532 Revenue: Gross Revenue $ 155,393,449 $ 166,103,989 $ 161,234,847 $ 170,586,964 $ 167,125,136 $ 168,704,378 $ 173,541,065 $ 163,203,707 $ 175,693,424 $ 163,742,001 $ 1,665,328,959 Deductions from Rev (114,548,915) (122,862,300) (119,724,189) (127,741,102) (125,413,158) (125,273,854) (131,424,654) (122,886,881) (131,500,841) (123,213,015) (1,244,588,911) Net Patient Revenue 40,844,534 43,241,689 41,510,658 42,845,862 41,711,978 43,430,524 42,116,411 40,316,826 44,192,583 40,528, ,740,048 Other Oper Revenue 830, ,270 1,385,488 1,006, ,986 1,105, , , ,606 1,039,023 9,779,677 Total Net Revenue 41,675,110 44,077,959 42,896,146 43,851,978 42,583,964 44,536,354 43,012,730 41,215,289 45,102,189 41,568, ,519,725 Expenses: Salaries, Wages & Contr Labor 19,549,232 19,771,982 19,149,834 19,809,340 19,638,785 20,359,334 20,497,235 19,674,969 21,297,055 20,835, ,583,197 Benefits 5,727,318 5,672,364 5,408,660 5,621,446 5,425,500 5,729,743 5,675,522 5,507,140 5,867,925 5,679,529 56,315,148 Supplies 6,138,762 6,222,648 6,340,266 6,186,979 6,162,802 6,711,095 6,273,748 5,799,051 6,718,960 6,260,073 62,814,383 Prof Fees & Purch Svc 5,728,447 5,938,803 5,818,583 6,038,706 5,924,010 6,190,737 5,806,359 5,913,798 5,813,634 5,633,283 58,806,361 Depreciation 1,811,075 1,797,915 1,789,316 1,795,535 1,795,429 1,801,732 1,728,752 1,737,997 1,738,299 1,750,513 17,746,562 Other 2,143,909 2,429,088 2,341,764 2,494,794 2,492,820 2,177,737 2,133,883 1,938,844 2,459,983 1,795,331 22,408,154 Total Expenses 41,098,743 41,832,800 40,848,423 41,946,800 41,439,346 42,970,378 42,115,499 40,571,799 43,895,856 41,954, ,673,805 Net Inc Before Non-Oper Income 576,367 2,245,159 2,047,723 1,905,178 1,144,618 1,565, , ,490 1,206,333 (386,150) 11,845,920 1 Property Tax Revenue 1,083,333 1,083,333 1,083,333 1,097,779 1,086,607 1,083,297 1,083,333 1,083,333 1,083,333 1,083,333 10,851, Non-Operating Income 599,642 (93,181) (488,961) 283,172 83, , ,583 (208,076) (261,787) 257,441 1,419,784 Net Income (Loss) $ 2,259,342 $ 3,235,311 $ 2,642,095 $ 3,286,129 $ 2,315,031 $ 3,485,420 $ 2,392,147 $ 1,518,747 $ 2,027,879 $ 954,624 $ 24,116,721 Net Income Margin 5.42% 7.34% 6.16% 7.49% 5.44% 7.83% 5.56% 3.68% 4.50% 2.30% 5.60% OEBITDA Margin w/o Prop Tax 5.73% 9.17% 8.94% 8.44% 6.90% 7.56% 6.11% 5.78% 6.53% 3.28% 6.87% OEBITDA Margin with Prop Tax 8.33% 11.63% 11.47% 10.94% 9.46% 9.99% 8.62% 8.41% 8.93% 5.89% 9.39% 1= Property Tax Revenue does not include G.O. Bonds Levy 2= Interest Expense does not include G.O. Bonds Interest

15 CASH FLOW STATEMENT 15 April YTD CASH FLOWS FROM OPERATING ACTIVITIES: Income (Loss) from operations (386,150) 11,845,920 Adjustments to reconcile change in net assets to net cash provided by operating activities: Depreciation Expense 1,750,513 17,746,562 Provision for bad debts 5,521,750 62,256,824 Changes in operating assets and liabilities: Patient accounts receivable (3,030,891) (82,064,117) Property Tax and other receivables 1,026,952 (27,328,739) Inventories 41, ,101 Prepaid expenses and other current assets 2,244,648 (1,559,566) Accounts payable 2,194,160 (30,630,001) Accrued compensation (1,095,717) 48,462 Estimated settlement amounts due third-party payors (280,022) (340,753) Other current liabilities 1,328,223 16,736,151 Net cash provided by operating activities 9,314,619 (33,172,152) CASH FLOWS FROM INVESTING ACTIVITIES: Net (purchases) sales of investments (311,041) 169,474,564 Income (Loss) on investments 386,754 2,173,335 Investment in affiliates 32,584 1,685,079 Net cash used in investing activities 108, ,332,978 CASH FLOWS FROM NON-CAPITAL FINANCING ACTIVITIES: Receipt of G.O. Bond Taxes 4,280,060 13,545,870 Receipt of District Taxes 3,438,990 11,325,349 Net cash used in non-capital financing activities 7,719,050 24,871,219 CASH FLOWS FROM CAPITAL AND RELATED FINANCING ACTIVITIES: Acquisition of property plant and equipment (12,576,555) (130,848,790) Deferred Financing Costs 115,125 1,151,408 G.O. Bond Interest paid 0 (12,032,382) Revenue Bond Interest paid (398,002) (16,612,464) Payments of Long Term Debt 0 (8,366,793) Net cash used in activities (12,859,432) (166,709,021) NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 4,282,534 (1,676,975) CASH AND CASH EQUIVALENTS - Beginning of period 6,001,282 11,960,791 CASH AND CASH EQUIVALENTS - End of period 10,283,816 10,283,816

16 FINANCIAL REPORT NARRATIVE STATISTICS 16 Mar vs Apr Apr Act vs Bud Mar Apr % Change Budget % Variance SOLIDATED Patient Days Acute 9,004 7,888 (12.4%) 8,440 (6.5%) Patient Days SNF 6,359 6,124 (3.7%) 6,173 (0.8%) ADC Acute (9.5%) (6.5%) ADC SNF (0.5%) (0.8%) Surgeries CVS Cases 9 8 (11.1%) 9 (11.1%) Surgeries Total 1,649 1,508 (8.6%) 1,538 (2.0%) Number of Births (4.8%) 410 (13.2%) NORTH Patient Days Acute 6,797 6,092 (10.4%) 6,285 (3.1%) Patient Days SNF 2,541 2, % 2, % ADC Acute (7.4%) (3.1%) ADC SNF % % SOUTH Patient Days Acute 2,207 1,796 (18.6%) 2,155 (16.7%) Patient Days SNF 3,818 3,527 (7.6%) 3,612 (2.4%) ADC Acute (15.9%) (16.7%) ADC SNF (4.5%) (2.4%)

17 FINANCIAL REPORT NARRATIVE BALANCE SHEET 17 Current Cash & Cash Equivalents increased $1.6 million from $159.5 million in March to $161.1 million in April. Total Cash and Investments are $170.7 million in April, compared to $169.6 million in March. Days Cash on Hand increased from days in March to days in April. Net Accounts Receivable decreased $2.5 million from $101.9 million in March to $99.4 million in April. Gross A/R days decreased from 51.0 days in March to 47.9 days in April. YTD collections, including capitation, are $384.1 million compared to budget of $420.0 million. Other Current Liabilities decreased $0.6 million from $26.1 million in March to $25.5 million in April. The decrease is due to the realization of deferred property tax revenue of $1.1 million which was partially offset by an increase in the capitation liability of $0.4 million and an increase in Other of $0.1 million. Construction-in-Progress increased $17.1 million from $1.05 billion in March to $1.06 billion in April. The increase is attributed to Building Expansion construction, equipment and interest costs of $17.0 million and Other of $0.1 million.

18 FINANCIAL REPORT NARRATIVE INCOME STATEMENT Gross Patient Revenue reflects a YTD favorable budget variance of $45.4 million. 18 North South Outreach Consolidated Total $ 55,777,977 $ (11,942,746) $ 1,595,875 $ 45,431,106 Routine 9,066,109 (5,828,129) - 3,237,980 IP Ancillary 13,274,207 (9,550,377) - 3,723,830 Outpatient 33,437,661 3,435,760 1,595,875 38,469,296 Net Capitation reflects a YTD favorable budget variance of $2.2 million. Capitation Premium and Out of Network Claim expense both show a favorable variance of $2.5 million and $2.0 million, respectively. The favorable variance in Capitation Premium is due to retro 2011 and 2010 premium adjustments in July and August. This favorable amount is offset by a $2.3 million increase in In-Network Claim expense. Salaries, Wages & Contract Labor reflect a YTD unfavorable budget variance of $3.6 million. YTD Actual YTD Budget Variance Consolidated $ 200,583,197 $ 197,004,120 $ (3,579,077) North 118,086, ,688,356 (5,397,993) South 49,553,411 50,357, ,016 Central 25,693,195 27,720,083 2,026,888 Outreach 7,250,242 6,238,254 (1,011,988) Employee Benefits Expense reflects a YTD unfavorable budget variance of $1.0 million due to an unfavorable budget variance in Pension of $1.5 million which was partially offset by favorable budget variances in Other of $0.5 million. Supplies reflect a YTD unfavorable budget variance of $2.1 million due to unfavorable budget variances in Surgery General of $1.2 million, Prosthesis of $0.6 million and Other of $0.3 million. Professional Fees, Purchased Services and Other Direct reflect a combined YTD favorable budget variance of $5.4 million. Ratios & Margins: All required Bond Covenant Ratios were achieved in April 2012.

19 KEY STATISTICAL INDICATORS YEAR-TO-DATE 19 ACTUAL BUDGET VARIANCE FY 2011 ADMISSIONS - Acute: Palomar Medical Center 16,168 16,550 (382) 16,484 Pomerado Hospital 5,279 5,605 (326) 5,451 Total: 21,447 22,155 (708) 21,935 ADMISSIONS - SNF: Palomar Medical Center Pomerado Hospital (23) 535 Total: 1, PATIENT DAYS - Acute: Palomar Medical Center 64,215 63, ,610 Pomerado Hospital 20,188 21,910 (1,722) 21,804 Total: 84,403 85,805 (1,402) 86,414 PATIENT DAYS- SNF: Palomar Medical Center 25,781 26,034 (253) 25,843 Pomerado Hospital 36,425 36,719 (294) 36,773 Total: 62,206 62,753 (547) 62,616

20 KEY STATISTICAL INDICATORS YEAR-TO-DATE 20 ACTUAL BUDGET VARIANCE FY 2011 EMERGENCY ROOM VISITS & TRAUMA CASES: Palomar Medical Center 48,110 47, ,934 Pomerado Hospital 21,613 21,705 (92) 21,703 Total: 69,723 69, ,637 EMERGENCY & TRAUMA ADMISSIONS: Palomar Medical Center 9,307 9,365 (58) 9,067 Pomerado Hospital 3,202 3,365 (163) 3,255 Total: 12,509 12,730 (221) 12,322 SURGERIES: Palomar Medical Center 9,987 10,361 (374) 9,279 Pomerado Hospital 5,121 5,280 (159) 5,231 Total: 15,108 15,641 (533) 14,510 BIRTHS: Palomar Medical Center 2,976 3,186 (210) 3,042 Pomerado Hospital (29) 937 Total: 3,932 4,171 (239) 3,979

21 KEY STATISTICAL INDICATORS YEAR-TO-DATE 21 ACTUAL BUDGET VARIANCE FY 2011 ADJUSTED DISCHARGES Palomar Medical Center 24,068 24,668 (600) 23,996 Pomerado Hospital 9,268 9,681 (413) 9,486 Other Activities (17) 228 Total: 33,532 34,562 (1,030) 33,710 AVERAGE LENGTH OF STAY- Acute: Palomar Medical Center Pomerado Hospital (0.05) 3.94 Total: AVERAGE LENGTH OF STAY - SNF: Palomar Medical Center Pomerado Hospital Total:

22 SUPPLIES EXPENSE YEAR-TO-DATE 22 Account Description Actual Budget Variance Supplies Surgery General 6,430,389 5,246,514 (1,183,875) Prosthesis 15,475,296 14,830,045 (645,251) Supplies Food Other 2,380,905 2,075,973 (304,932) Supplies Oxygen/Gas 252,763 74,903 (177,860) Supplies Surgical Pack 1,926,925 1,789,731 (137,194) Sutures/Surgical Needles 1,909,808 1,809,904 (99,904) Supplies IV Solutions 481, ,304 (62,413) Supplies Anesthesia Material 90,278 42,814 (47,464) Supplies Employee Apparel 204, ,922 (42,942) Supplies Other Medical 12,020,275 12,004,858 (15,417) Supplies Food/Meat 520, ,566 (10,459) Supplies Cleaning 409, ,337 (8,386) Other Minor Equipment 1,459,182 1,459, Supplies Linen 24,557 28,545 3, Supplies X-ray Material 12,439 20,744 8, Supplies Radioactive 534, ,412 48, Supplies Office/Administration 851, ,684 78, Supplies Forms 275, ,792 94, Supplies Pharmaceutical 9,772,175 9,879, , Instruments/Minor Equipment 750, , , Other Non Medical 7,030,431 7,180, ,712 Total 62,814,383 60,710,562 (2,103,821)

23 (1) The 2010 Certificates of Participation interest is pre-funded through November 1, 2012, therefore, by definition, they are excluded from the maximum annual debt service total for these ratios. FISCAL YEAR 2012 BOND COVENANT RATIOS 23 Cushion Ratio Jun-10 Jun-11 Apr-12 Cash and Cash Equivalents 171,574, ,301, ,107,302 Board Designated Reserves - - 9,258,782 Trustee-held Funds (Revenue Fund only) 3,085 20,275 28,107 Total 171,577, ,321, ,394,191 Divided by: Maximum Annual Debt Service (excludes GO Bonds) (1) 13,766,910 13,769,523 29,699,638 (Fiscal Year 6/30/2040) Cushion Ratio REQUIREMENT Achieved Achieved Achieved Days Cash on Hand Jun-10 Jun-11 Apr-12 Cash and Cash Equivalents 171,574, ,301, ,107,302 Board Designated Reserves - - 9,258,782 Trustee-held Funds (Revenue Fund only) 3,085 20,275 28,107 Total 171,577, ,321, ,394,191 Divide Total by Average Adjusted Expenses per Day Total Expenses 451,348, ,493, ,673,805 Less: Depreciation 21,358,985 21,345,777 17,746,562 Adjusted Expenses 429,989, ,147, ,927,243 Number of days in period Average Adjusted Expenses per Day 1,178,053 1,252,459 1,314,516 Days Cash on Hand REQUIREMENT Achieved Achieved Achieved Debt Service Coverage Ratio Jun-10 Jun-11 Apr-12 Excess of revenues over expenses YTD 24,487,453 30,967,811 24,116,721 (General Funds) ADD: Depreciation and Amortization 21,358,985 21,345,777 17,746,562 Interest Expense 4,628,028 3,805,187 2,374,780 Market Value Adj - Auction Rate Securities 7,570,218 (4,859,396) 0 Income Available for Debt Service 58,044,684 51,259,379 44,238,063 Divided by: Maximum Annual Debt Service (excludes GO Bonds) (1) 14,724,311 13,768,652 24,749,698 (Fiscal Year 6/30/2040) Debt Service Coverage Ratio REQUIREMENT Achieved Achieved Achieved

24 Statistical Indicators Discharges - Acute 24 2,500 2,000 1,500 1, JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD 1,595 1,697 1,645 1,564 1,606 1,648 1,589 1,548 1,689 1, ,108 16, ,319 5,695 2,151 2,255 2,187 2,080 2,130 2,247 2,134 2,015 2,239 1, ,427 22,314

25 Statistical Indicators Patient Days - Acute 25 10,000 9,000 8,000 7,000 6,000 5,000 4,000 3,000 2,000 1,000 - JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD 6,057 6,462 6,315 6,623 6,476 6,556 6,651 6,186 6,797 6, ,215 63,895 2,140 1,926 1,917 1,996 1,952 2,193 2,215 1,846 2,207 1, ,188 21,910 8,197 8,388 8,232 8,619 8,428 8,749 8,866 8,032 9,004 7, ,403 85,805

26 Statistical Indicators Average Length of Stay - Acute JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD

27 Statistical Indicators Average Daily Census - Acute JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD

28 Statistical Indicators Patient Days 28 JUN - MAY - APR 1, , , MAR 1, , , , FEB , , JAN 1, , , DEC 1, , , NOV 1, , OCT 1, , , SEP , AUG 1, , , JUL 1, , PY AVG 1, , ,000 4,000 6,000 8,000 10,000 ICU/CCU Telemetry IMC Med-Oncology Surg-Ortho Med Surg Labor Delivery Recovery Rehb Acute MHU NICU JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD 6,057 6,462 6,315 6,623 6,476 6,556 6,651 6,186 6,797 6, ,215 63,895 2,140 1,926 1,917 1,996 1,952 2,193 2,215 1,846 2,207 1, ,188 21,910 8,197 8,388 8,232 8,619 8,428 8,749 8,866 8,032 9,004 7, ,403 85,805

29 Statistical Indicators Surgeries (Inpatient only) JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD ,074 5, ,679 1, ,753 6,810

30 Statistical Indicators Surgeries (Outpatient only) 30 1,200 1, JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD ,829 5, ,442 3, ,271 8,735

31 Statistical Indicators Surgeries CVS ( only) JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD

32 Statistical Indicators Total Surgeries 32 1,800 1,600 1,400 1,200 1, JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD 908 1,013 1, , , , ,987 10, ,121 5,280 1,391 1,546 1,520 1,507 1,512 1,523 1,497 1,455 1,649 1, ,108 15,641

33 Statistical Indicators Outpatient Registrations (excludes Lab) 33 7,000 6,000 Oct-11 registrations are high as recurring encounters were discharged on Sep 30, New encounters were created on Oct 1, ,000 4,000 3,000 2,000 1,000 - JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD 2,180 2,677 2,862 3,473 2,733 2,449 2,744 2,639 3,083 2, ,656 24,082 1,862 2,164 2,004 2,293 1,931 2,130 1,992 2,019 2,155 2, ,580 20,995 4,042 4,841 4,866 5,766 4,664 4,579 4,736 4,658 5,238 4, ,236 45,077

34 Statistical Indicators ER Visits (includes Trauma, Outpatient only) 34 8,000 7,000 6,000 5,000 4,000 3,000 2,000 1,000 - JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD 4,864 4,816 4,779 5,004 4,393 4,560 5,190 4,719 5,055 4, ,110 47,431 2,118 2,241 1,966 2,113 2,104 2,099 2,311 2,241 2,241 2, ,613 21,705 6,982 7,057 6,745 7,117 6,497 6,659 7,501 6,960 7,296 6, ,723 69,136 /DAY

35 Statistical Indicators ER Admissions (includes Trauma, Inpatient only) 35 1,600 1,400 1,200 1, JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD ,307 9, ,202 3,365 1,265 1,237 1,243 1,225 1,245 1,287 1,347 1,219 1,287 1, ,509 12,730

36 Statistical Indicators Total ER Visits (includes Trauma & Admissions) 36 10,000 9,000 8,000 7,000 6,000 5,000 4,000 3,000 2,000 1,000 - JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD 5,830 5,731 5,699 5,930 5,321 5,478 6,164 5,632 6,023 5, ,417 56,796 2,417 2,563 2,289 2,412 2,421 2,468 2,684 2,547 2,560 2, ,815 25,070 8,247 8,294 7,988 8,342 7,742 7,946 8,848 8,179 8,583 8, ,232 81,866

37 Statistical Indicators ER Conversion (ER Admits as % of ER Visits) JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD

38 Statistical Indicators Trauma Cases ( only) JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD , ,

39 Statistical Indicators Trauma Admissions ( only) JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD

40 Statistical Indicators Deliveries JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD ,976 3, ,932 4,171

41 Payor Mix Based on Gross Revenue 41 JUN MAY APR MAR FEB JAN DEC NOV OCT SEP AUG JUL PY AVG % 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% MEDICARE MCAR MGD MEDI-CAL MCAL MGD SELF PAY MGD CARE CAP OTHER

42 Case Mix Index JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD

43 Case Mix Index by Region (excludes Deliveries) JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD

44 Case Mix Index by Region Medicare JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD

45 Adjusted Discharges Gross Patient Revenue per Adjusted Discharges 45 54,000 Dollars per Adjusted Discharge 52,000 50,000 48,000 46,000 44,000 42,000 40,000 JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD 47,313 47,614 48,486 54,048 52,585 49,986 52,317 50,139 49,736 51, ,370 46,883 44,683 46,267 44,417 50,420 46,584 47,171 49,619 49,894 47,619 50, ,627 46,829 46,609 47,269 47,436 53,126 51,031 49,214 51,603 50,078 49,186 51, ,664 46,869

46 Adjusted Discharges Net Patient Revenue per Adjusted Discharges 46 15,250 Dollars per Adjusted Discharge 14,250 13,250 12,250 11,250 10,250 JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD 11,579 11,921 11,768 12,729 12,318 12,112 11,810 11,941 11,707 11, ,932 11,713 13,377 12,788 12,741 14,273 13,040 13,462 13,625 12,817 13,362 15, ,483 13,304 12,251 12,306 12,213 13,343 12,736 12,669 12,523 12,371 12,372 12, ,547 12,301

47 Adjusted Discharges Salaries per Adjusted Discharges 47 6,500 Dollars per Adjusted Discharge 6,000 5,500 5,000 4,500 4,000 3,500 JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD 4,875 4,564 4,542 4,956 4,957 5,017 5,077 4,919 4,930 5, ,906 4,568 5,379 5,086 5,164 5,576 5,099 5,166 5,394 5,557 5,294 5, ,347 5,202 5,864 5,627 5,634 6,169 5,997 5,939 6,095 6,037 5,962 6, ,982 5,700

48 Adjusted Discharges Supplies per Adjusted Discharges 48 2,200 Dollars per Adjusted Discharge 2,100 2,000 1,900 1,800 1,700 1,600 1,500 JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD 1,599 1,882 1,831 1,823 1,768 1,952 1,816 1,700 1,915 1, ,824 1,688 1,801 1,878 1,760 1,846 2,215 1,770 1,824 1,798 1,782 1, ,852 1,784 1,841 1,771 1,865 1,927 1,882 1,958 1,866 1,779 1,881 1, ,873 1,757

49 Adjusted Discharges Total Expenses per Adjusted Discharges 49 15,000 Dollars per Adjusted Discharge 14,000 13,000 12,000 11,000 10,000 JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD 11,385 11,162 10,888 11,947 12,022 11,823 11,566 11,549 11,553 12, ,591 11,265 13,488 12,538 13,335 13,551 13,663 12,782 13,335 13,874 12,653 14, ,321 13,201 12,327 11,905 12,018 13,063 12,653 12,535 12,523 12,449 12,289 13, ,486 12,139

50 Adjusted Discharges Net Operating Income per Adjusted Discharges 50 2,500 2,000 Dollars per Adjusted Discharge 1,500 1, (500) (1,000) (1,500) (2,000) (2,500) JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD , (515) (62) 298 (536) 788 (579) (984) 769 1, (122)

51 PFS MONTHLY CASH COLLECTIONS 51 Millions $44.0 $40.0 $36.0 $32.0 $28.0 $24.0 $20.0 PPH Monthly Collections in Millions July Aug. Sept. Oct. Nov. Dec. Jan. Feb. March April May June FY12 Goal $42.0 $42.0 $42.0 $42.0 $42.0 $42.0 $42.0 $42.0 $42.0 $42.0 $42.0 $42.0 Curr. Yr Actual $33.8 $39.5 $37.0 $41.6 $36.4 $37.7 $38.2 $37.3 $41.0 $41.6 Pr. Yr Actual $37.1 $36.9 $33.7 $37.8 $39.7 $43.7 $39.1 $39.3 $44.0 $34.1 $37.7 $43.7

52 HEALTHWORX DASHBOARD REVENUE CYCLE KEY INDICATORS 52

53 SUPPLEMENTAL INFORMATION 53

54 WEEKLY FLASH REPORT 54 Volume 5/10/2012 5/17/2012 5/24/2012 5/31/2012 MTD Total MTD Budget % Variance Palomar Medical Center Average daily census (1.73) Acute Patient Days 1,441 1,441 1,466 (1.73) PCCC Days Acute Discharges (9.97) Observation Discharges Births OP Visits w/o Lab Lab Registrations (31.98) ED Visits 1,329 1,329 1, Trauma Admits Trauma Outpatient (75.00) Inpatient surgeries (5.71) Outpatient surgeries (0.99) Pomerado Hospital Average daily census (10.51) Acute Patient Days (10.51) VP Days (0.62) Acute Discharges (7.63) Observation Discharges Births OP Visits w/o Lab (2.07) Lab Registrations (13.10) ED visits Inpatient surgeries (6.67) Outpatient surgeries (17.65)

55 WEEKLY FLASH REPORT 55 Financial and Acuity 5/10/2012 5/17/2012 5/24/2012 5/31/2012 MTD Total MTD Budget % Variance Palomar Medical Center Gross Inpatient Charges $ 19,282,991 $ 19,282,991 $ 18,752, Gross Outpatient Charges $ 8,951,578 $ 8,951,578 $ 7,789, Average Length of Stay Acute Case Mix Index 1.33 Pomerado Hospital Gross Inpatient Charges $ 6,609,051 $ 6,609,051 $ 6,677,214 (1.02) Gross Outpatient Charges $ 3,916,608 $ 3,916,608 $ 3,723, Average Length of Stay (3.12) Acute Case Mix Index 1.36 Productivity and Cash Cash Collection 15,303,486 15,303,486 18,000,000 (14.98) Dollars Held in Billing Edits 2,866,513 2,866,513 3,000, Days Cash on Hand Productivity Hrs (PP 23) 235, , ,005 (7.45) 133, , ,778 (6.77) 58,937 58,937 56,559 (4.20) Others 43, ,164 37,668 (14.59) Productivity $$$ (PP 23) 8,460,130 8,460,130 8,103,968 (4.39) 4,780,407 4,780,407 4,628,567 (3.28) 2,017,680 2,017,680 1,979,885 (1.91) Others 1,662, ,662,043 1,495,516 (11.14)

(Cifras en millones de pesos colombianos) / (Amounts stated in millions of Colombian pesos) CONCEPTO / CONCEPT

(Cifras en millones de pesos colombianos) / (Amounts stated in millions of Colombian pesos) CONCEPTO / CONCEPT BOLSA DE VALORES DE COLOMBIA S.A. Y SUBSIDIARIAS / BOLSA DE VALORES DE COLOMBIA S.A. AND SUBSIDIARIES ESTADOS DE RESULTADO INTEGRAL CONSOLIDADOS / CONSOLIDATED STATEMENT AT OF PROFIT OR LOSS AND OTHER

Más detalles

Banco Santander s balance sheet and income statement

Banco Santander s balance sheet and income statement Banco Santander s balance sheet and income statement Banco Santander s balance sheet and income statement Balance sheet at 31 december 2016 with distribution of income ASSETS December 2016 Cash, cash balances

Más detalles

Generando Records con Pequeños Agricultores

Generando Records con Pequeños Agricultores Generando Records con Pequeños Agricultores Incluyendo Educación Financiera! Haciendo la agricultura mas rentable Presented by the UTPA Risk Management Project Risk Management for Hispanic and Other Small

Más detalles

CONCEPTO / CONCEPT Mar-15 Mar-14

CONCEPTO / CONCEPT Mar-15 Mar-14 ESTADOS DE RESULTADO INTEGRAL CONSOLIDADOS / CONSOLIDATED STATEMENT AT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME Ingresos / Revenues 20.921 22.824 (1.903) -8% Ingresos ordinarios / Ordinary revenues

Más detalles

GRANTS % (14,798.25) -28%

GRANTS % (14,798.25) -28% PRIOR YEAR BUDGET 201516 ACTUAL STATEMENT OF ACTIVITIES AND CHANGES IN NET ASSETS For the Five Months Ended November 30, 2015 ACTUAL vs BUDGET % ACTUAL vs PRIOR YEAR % Revenues 53,082.75 37,769.50 38,284.50

Más detalles

INDIVIDUAL FINANCIAL STATEMENTS

INDIVIDUAL FINANCIAL STATEMENTS ESTADOS FIN INDIVIDUAL FINANCIAL STATEMENTS 210 ANCIEROS Memoria Annual report 2007 ES Detalle del edificio Terminal del Aeropuerto de Albacete. Terminal Building at Albacete Airport. 211 Información legal

Más detalles

ANEXO 1. Comportamiento de la Industria Aérea en EE.UU.

ANEXO 1. Comportamiento de la Industria Aérea en EE.UU. ANEXO 1. Comportamiento de la Industria Aérea en EE.UU. Figura 1.0 Trafico Anual de la Industria Aérea Figura 1.1 Utilidad Operativa y Gastos Anuales Figura 1.0 Utilidad Neta Industria Aérea Figura 1.1

Más detalles

3Estados Financieros Financial Statements

3Estados Financieros Financial Statements 3Estados Financieros Financial Statements LARRAÍN VIAL S.A. CORREDORA DE BOLSA LARRAÍN VIAL S.A. CORREDORA DE BOLSA BALANCE GENERAL OS Activos Efectivo y efectivo equivalente 30.229.995 24.340.715 Instrumentos

Más detalles

INFORMACIÓN FINANCIERA FINANCIAL INFORMATION

INFORMACIÓN FINANCIERA FINANCIAL INFORMATION INFORMACIÓN FINANCIERA FINANCIAL INFORMATION INFORMACIÓN FINANCIERA FINANCIAL INFORMATION INFORMACIÓN FINANCIERA FINANCIAL INFORMATION El patrimonio neto de la Fundación alcanzó, a fecha 31 de diciembre

Más detalles

Premios Mayma Finanzas para Planes de Negocios

Premios Mayma Finanzas para Planes de Negocios CONFIDENCIAL Premios Mayma Finanzas para Planes de Negocios Buenos Aires, 16 de octubre de 2013 Fernando Chuit Co-fundador y Director Equitas Ventures El presente documento es solamente para uso exclusivo

Más detalles

Earnings Release Presentation

Earnings Release Presentation - 2Q11 Este documento ha sido preparado por Celfìn Capital (en adelante el Agente Estructurador y Colocador ) en conjunto con SONDA S.A. (en adeante SONDA, el Emisor o la Compañía ) en base a información

Más detalles

GLOSARIO DE TÉRMINOS FINANCIEROS EN ESPAÑOL E INGLÉS GLOSSARY OF FINANCIAL TERMS IN ENGLISH AND SPANISH

GLOSARIO DE TÉRMINOS FINANCIEROS EN ESPAÑOL E INGLÉS GLOSSARY OF FINANCIAL TERMS IN ENGLISH AND SPANISH Página 1 de 7 Page 1 of 7 GLOSARIO DE TÉRMINOS FINANCIEROS EN ESPAÑOL E INGLÉS GLOSSARY OF FINANCIAL TERMS IN ENGLISH AND SPANISH Estados financieros Estados financieros consolidados Balance general Estado

Más detalles

Estados financieros individuales Individual balance sheets

Estados financieros individuales Individual balance sheets Estados financieros individuales Individual balance sheets Área comercial del Aeropuerto de Palma de Mallorca. Commercial area at Palma de Mallorca Airport. 234 Memoria 2008 Annual report 2008 Información

Más detalles

DOCUMENT 6 REGIONAL TREASURER S REPORT

DOCUMENT 6 REGIONAL TREASURER S REPORT DOCUMENT 6 REGIONAL TREASURER S REPORT World Scout Bureau Interamerican Region November 2018 Table of Contents World Scout Bureau Interamerican Region... 1 Significant Events Identified Impacting the

Más detalles

INFORME DE LOS AUDITORES INDEPENDIENTES INDEPENDENT AUDITORS' REPORT. A la Junta Directiva de Asociación Instituto Nacional de Biodiversidad (INBio):

INFORME DE LOS AUDITORES INDEPENDIENTES INDEPENDENT AUDITORS' REPORT. A la Junta Directiva de Asociación Instituto Nacional de Biodiversidad (INBio): Deloitte & Touche, S.A. Barrio Dent, San Pedro 3667-1000 San José Costa Rica Tel: (506) 2246 5000 Fax: (506) 2246 5100 www.deloitte.com INFORME DE LOS AUDITORES INDEPENDIENTES A la Junta Directiva de Asociación

Más detalles

BOARD OF TRUSTEES MEETING AGENDA

BOARD OF TRUSTEES MEETING AGENDA BOARD OF TRUSTEES MEETING AGENDA October 25, 217 6: PM - 8: PM I. Cal to Order & Roll-call II. III. IV. Approval of the Agenda Approval of the Minutes Officer and Committee Reports Chairman s Report School-at-Large

Más detalles

Section 6621 of the Internal Revenue Code establishes the interest rates on

Section 6621 of the Internal Revenue Code establishes the interest rates on Part 1 Section 6621.--Determination of Rate of Interest 26 CFR 301.6621-1: Interest rate. Rev. Rul. 2014-29 Section 6621 of the Internal Revenue Code establishes the interest rates on overpayments and

Más detalles

Contribution Margin ,6%

Contribution Margin ,6% Table 1 CONSOLIDATED INCOME STATEMENT (Million Ch$) (Thousand US$) 1H2015 1H2014 Var 1H2014-1H2015 Chg % 1H2015 Sales 3.463.217 3.173.127 290.090 9,1% 5.573.160 Energy sales 3.194.351 2.932.237 262.114

Más detalles

MEXICAN STOCK EXCHANGE

MEXICAN STOCK EXCHANGE STOCK EXCHANGE CODE: GIGANTE STATEMENT OF FINANCIAL POSITION QUARTER: 4 YEAR: 215 REF AT 31 DECEMBER 215 AND 31 DECEMBER 214 (Thousand Pesos) ACCOUNT / SUBACCOUNT ENDING CURRENT PREVIOUS YEAR END Amount

Más detalles

III_ ESTADOS FINANCIEROS FINANCIAL STATEMENTS

III_ ESTADOS FINANCIEROS FINANCIAL STATEMENTS III_ ESTADOS FINANCIEROS FINANCIAL STATEMENTS LARRAÍN VIAL S.A. CORREDORA DE BOLSA LARRAÍN VIAL S.A. CORREDORA DE BOLSA ESTADOS FINANCIEROS / FINANCIAL STATEMENTS 67 BALANCE GENERAL Periodos EFECTIVO

Más detalles

INFORMACIÓN FINANCIERA FINANCIAL INFORMATION

INFORMACIÓN FINANCIERA FINANCIAL INFORMATION INFORMACIÓN FINANCIERA FINANCIAL INFORMATION INFORMACIÓN FINANCIERA FINANCIAL INFORMATION INFORMACIÓN FINANCIERA FINANCIAL INFORMATION El patrimonio neto de la Fundación alcanzó, a fecha 31 de diciembre

Más detalles

Pacífico Peruano Suiza

Pacífico Peruano Suiza Pacífico Peruano Suiza 2001 Contenido Contents US$ S/. Dólar estadounidense United States dollar Nuevos Soles Peruvian new sol 31 de diciembre del 2001 y 31 de diciembre del 2000 December 31, 2001 and

Más detalles

Mortgage Statistics (M) December 2017 and Year Provisional data

Mortgage Statistics (M) December 2017 and Year Provisional data 28 February 2018 Mortgage Statistics (M) December 2017 and Year 2017. Provisional data The total number of mortgages constituted on dwellings recorded in the land registries stands at 20,681 in December,

Más detalles

ESTADOS FINANCIEROS / 1FINANTIAL SITUATION

ESTADOS FINANCIEROS / 1FINANTIAL SITUATION 1.1 BALANCE DE SITUACIÓN (31-12-2015) / BALANCE SHEET (31-12-2015) Activo / Assets 2015 2014 A) ACTIVO NO CORRIENTE / NON-CURRENT ASSETS 492.600.398,42 492.467.640,40 I. Inmovilizado intangible / Intangible

Más detalles

Mortgage Statistics (M) March Provisional data

Mortgage Statistics (M) March Provisional data 30 May 2017 Mortgage Statistics (M) March 2017. Provisional data The total number of mortgages constituted on dwellings recorded in the land registries stands at 27,720 in March, 20.2% higher than in the

Más detalles

MERCADOLIBRE, INC. ANUNCIA RESULTADOS FINANCIEROS DEL TERCER TRIMESTRE Y PRIMEROS NUEVE MESES DE 2007

MERCADOLIBRE, INC. ANUNCIA RESULTADOS FINANCIEROS DEL TERCER TRIMESTRE Y PRIMEROS NUEVE MESES DE 2007 MERCADOLIBRE, INC. ANUNCIA RESULTADOS FINANCIEROS DEL TERCER TRIMESTRE Y PRIMEROS NUEVE MESES DE 2007 ~ Las ventas del tercer trimestre se incrementaron un 72,4% a $22,8 millones ~ ~ El ingreso operativo

Más detalles

Atlantic Security Holding Corporation

Atlantic Security Holding Corporation Atlantic Security Holding Corporation 2001 Contenido Contents 31 de diciembre del 2001 y 31 de diciembre del 2000 December 31, 2001 and December 31, 2000 Atlantic Security Holding Corporation y Subsidiarias

Más detalles

Balance de situación 2014 Balance-sheet Cuenta de pérdidas y ganancias 2014 Profits and loss account Estado de flujos de efectivo

Balance de situación 2014 Balance-sheet Cuenta de pérdidas y ganancias 2014 Profits and loss account Estado de flujos de efectivo Balance de situación 2014 Balance-sheet 2014 1.1 Cuenta de pérdidas y ganancias 2014 Profits and loss account 2014 1.2 Estado de flujos de efectivo 2014 Cash flow statement 2014 1.3 Estado de cambios en

Más detalles

Grupo Bafar with two digit growth in Operating Income and Operation Flow

Grupo Bafar with two digit growth in Operating Income and Operation Flow THIRD QUARTER RESULTS FOR 2011 Grupo Bafar with two digit growth in Operating Income and Operation Flow Third Quarter 2011 versus Third Quarter 2010 Sales volumes increased by 6.3% Sales increased in 6.1

Más detalles

Contribution Margin ( ) (4,5%)

Contribution Margin ( ) (4,5%) Table 1 CONSOLIDATED INCOME STATEMENT (Million Ch$) (Thousand US$) 2011 2012 Var 20112012 Chg % 2012 Sales 6.254.252 6.260.309 6.057 0,1% 12.865.676 Energy sales 5.805.296 5.793.164 (12.132) (0,2%) 11.905.637

Más detalles

Workers Compensation Premium Credits to Reflect 2017 Reforms

Workers Compensation Premium Credits to Reflect 2017 Reforms New York Compensation Insurance Rating Board 733 Third Avenue New York, NY 10017 Tel: (212) 697 3535 July 28, 2017 R.C. 2439 Re: Workers Compensation Premium Credits to Reflect 2017 Reforms Members of

Más detalles

In December, the number of property transfers registered is 124,616 properties, that is, 9.2% more than in the same month of 2013

In December, the number of property transfers registered is 124,616 properties, that is, 9.2% more than in the same month of 2013 10 February 2015 Statistics on Transfer of Property Rights (STPR) December 2014 and Year 2014. Provisional data In December, the number of property transfers registered is 124,616 properties, that is,

Más detalles

ESTADOS FINANCIEROS CAPÍTULO 1. Balance Sheets Chapter 1

ESTADOS FINANCIEROS CAPÍTULO 1. Balance Sheets Chapter 1 ESTADOS FINANCIEROS CAPÍTULO 1 Balance Sheets Chapter 1 1.1 Balance al cierre del ejercicio 2013 Balance sheet as of December 31st, 2013 ACTIVO / ASSETS 2013 2012 A) ACTIVO NO CORRIENTE / NON CURRENT ASSETS

Más detalles

BALANCE AL CIERRE DEL EJERCICIO 2012 (en euros)

BALANCE AL CIERRE DEL EJERCICIO 2012 (en euros) BALANCE AL CIERRE DEL EJERCICIO 2012 ACTIVO 2012 2011 PATRIMONIO NETO Y PASIVO 2012 2011 A) ACTIVO NO CORRIENTE 219.022.077,22 220.627.198,09 A) PATRIMONIO NETO 182.346.279,48 179.479.436,14 I. Inmovilizado

Más detalles

INFORMACIÓN FINANCIERA FINANCIAL INFORMATION

INFORMACIÓN FINANCIERA FINANCIAL INFORMATION INFORMACIÓN FINANCIERA FINANCIAL INFORMATION ÍNDICE CONTENTS INFORMACIÓN FINANCIERA FINANCIAL INFORMATION INFORMACIÓN FINANCIERA FINANCIAL INFORMATION El patrimonio neto de la Fundación alcanzó, a fecha

Más detalles

ISSUERS WITH THE LARGER STOCK EXCHANGE CAPITALIZATION

ISSUERS WITH THE LARGER STOCK EXCHANGE CAPITALIZATION IN MILLIONS OF PESOS % Variation during the month % Variation during yhe year % Variation year to date IN DOLLARS % Variation during the month % Variation during the year % Variation year to date MARKET

Más detalles

In March, 9,271 mercantile companies are created, 12.1% less than in the same month of 2017 and 1,752 are dissolved, 12.0% less

In March, 9,271 mercantile companies are created, 12.1% less than in the same month of 2017 and 1,752 are dissolved, 12.0% less 10 May 2018 Mercantile Companies Statistics (MC) March 2018. Provisional data In March, 9,271 mercantile companies are created, 12.1% less than in the same month of 2017 and 1,752 are dissolved, 12.0%

Más detalles

Corferias Second quarter results 2015

Corferias Second quarter results 2015 Corferias Second quarter results 2015 Table of contents I. Significant events II. Second quarter-exhibitions III. Financial situation IV. Fairs and events to run in the third quarter V. Questions I. Significant

Más detalles

AUTORIDAD PORTUARIA D Balance al cierre de (en eur

AUTORIDAD PORTUARIA D Balance al cierre de (en eur AUTORIDAD PORTUARIA D Balance al cierre de (en eur ACTIVO Nota 2013 2012 A) ACTIVO NO CORRIENTE 224.011.232,17 219.022.077,22 I. Inmovilizado intangible Nota 7 68.678,81 77.001,16 1. Propiedad industrial

Más detalles

In September, the number of property transfers registered is 123,642 properties, that is, 1.5% less than in the same month of the previous year

In September, the number of property transfers registered is 123,642 properties, that is, 1.5% less than in the same month of the previous year 11 November 2014 Statistics on Transfer of Property Rights (STPR) September 2014. Provisional data In September, the number of property transfers registered is 123,642 properties, that is, 1.5% less than

Más detalles

COMUNICACIÓN DE HECHO RELEVANTE GRUPO MASMOVIL. 14 de julio de 2017

COMUNICACIÓN DE HECHO RELEVANTE GRUPO MASMOVIL. 14 de julio de 2017 COMUNICACIÓN DE HECHO RELEVANTE GRUPO MASMOVIL 14 de julio de 2017 En virtud de lo previsto en el artículo 17 del Reglamento (UE) nº 596/2014 sobre abuso de mercado y en el artículo 228 del texto refundido

Más detalles

MEXICAN STOCK EXCHANGE

MEXICAN STOCK EXCHANGE STOCK EXCHANGE CODE: GRUPO INDUSTRIAL SALTILLO, S.A.B. DE C.V. STATEMENT OF FINANCIAL POSITION QUARTER: 2 YEAR: 215 REF AT 3 JUNE 215 AND 31 DECEMBER 214 (Thousand Pesos) ACCOUNT / SUBACCOUNT ENDING CURRENT

Más detalles

In May, 8,830 mercantile companies are created, 0.5% more than in the same month of 2017 and 1,522 are dissolved, 0.8% more

In May, 8,830 mercantile companies are created, 0.5% more than in the same month of 2017 and 1,522 are dissolved, 0.8% more 10 July 2018 Mercantile Companies Statistics (MC) May 2018. Provisional data In May, 8,830 mercantile companies are created, 0.5% more than in the same month of 2017 and 1,522 are dissolved, 0.8% more

Más detalles

BENEFICIO NETO ORDINARIO DE ENEL AUMENTÓ 18,6% EN EL PRIMER TRIMESTRE DE 2017 POR MENORES GASTOS FINANCIEROS Y REDUCCIÓN DEL INTERÉS DE MINORITARIOS

BENEFICIO NETO ORDINARIO DE ENEL AUMENTÓ 18,6% EN EL PRIMER TRIMESTRE DE 2017 POR MENORES GASTOS FINANCIEROS Y REDUCCIÓN DEL INTERÉS DE MINORITARIOS Media Relations Investor Relations T +39 06 8305 5699 T +39 06 8305 7975 F +39 06 8305 3771 F +39 06 8305 7940 ufficiostampa@enel.com investor.relations@enel.com enel.com enel.com BENEFICIO NETO ORDINARIO

Más detalles

2,000 1,800 COL20 - COLCAP 1,600 1,400 1,200 1,000. Mar-2,009. Jun-2,008. Aug-2,008. Number of Transactions. Jan-2,008. Jan-2,009.

2,000 1,800 COL20 - COLCAP 1,600 1,400 1,200 1,000. Mar-2,009. Jun-2,008. Aug-2,008. Number of Transactions. Jan-2,008. Jan-2,009. OLAP OL2 IGB INDIATORS TO SEPTEMBER 2,13 1,7.26 1,31% 4,23% -4,39% 1,311.19 4,39% -2,66% -2,73% 14,61.2 2,4%,3% -4,45% SEP - 2,13 Minimum Maximum DATE 2-SEP-2,13 25-SEP-2,13 OLAP 1,732. 1,777. DATE 2-SEP-2,13

Más detalles

ICA CORP FORM 6-K. (Report of Foreign Issuer) Filed 08/10/06 for the Period Ending 06/30/06

ICA CORP FORM 6-K. (Report of Foreign Issuer) Filed 08/10/06 for the Period Ending 06/30/06 ICA CORP FORM 6-K (Report of Foreign Issuer) Filed 08/10/06 for the Period Ending 06/30/06 Telephone 2124800111 CIK 0000885012 Symbol ICA SIC Code 1600 - Heavy Construction Other Than Bldg Const - Contractors

Más detalles

BANCO INVEX, S.A., INSTITUCION DE BANCA MULTIPLE, INVEX GRUPO FINANCIERO FIDEICOMISO /TRUST No. 581 "PATRIMONIO" INFORME/REPORT No. 2014-6 Periodo / Period Fecha Inicio / Start Date 01-jun-14 Fecha Final

Más detalles

In December, 6,741 mercantile companies are created, 8.4% less than in the same month of the previous year, and 2,585 are dissolved, 0.

In December, 6,741 mercantile companies are created, 8.4% less than in the same month of the previous year, and 2,585 are dissolved, 0. 9 February 2018 Mercantile Companies Statistics (MC) December 2017 and year 2017. Provisional data In December, 6,741 mercantile companies are created, 8.4% less than in the same month of the previous

Más detalles

AUTORITAT PORTUÀRIA DE BALEARS I ANNUAL REPORT 2014

AUTORITAT PORTUÀRIA DE BALEARS I ANNUAL REPORT 2014 1 18 AUTORITAT PORTUÀRIA DE BALEARS I ANNUAL REPORT 2014 1 Estados financieros Financial reports 1.1 CUENTA DE PÉRDIDAS Y GANANCIAS CORRESPONDIENTE AL EJERCICIO TERMINADO EL 31-12-13 PROFIT AND LOSS STATEMENT

Más detalles

CONTABILIDAD PARA PYMES POR: GABRIEL HERNÁNDEZ, CPA

CONTABILIDAD PARA PYMES POR: GABRIEL HERNÁNDEZ, CPA CONTABILIDAD PARA PYMES POR: GABRIEL HERNÁNDEZ, CPA A division of Agenda Componentes básicos de un Estado Financiero Cómo maximizar el manejo de flujo de efectivo? COMPONENTES BÁSICOS DE UN ESTADO FINANCIERO

Más detalles

BALANCE SHEET AS OF MARCH 31 OF 2014 AND 2013 (Million COP)

BALANCE SHEET AS OF MARCH 31 OF 2014 AND 2013 (Million COP) ASSETS 2014 2013 CURRENT ASSETS Cash 364.785 227.090 Portfolio Investments, net 3.310 7.463 Account receivable, net 302.393 367.924 Prepaid expenses 14.307 24.353 Other assets 9.995 131.090 Inventories,

Más detalles

Georgia Tech Financial Analysis Lab 800 West Peachtree Street NW Atlanta, GA

Georgia Tech Financial Analysis Lab 800 West Peachtree Street NW Atlanta, GA 800 West Peachtree Street NW Atlanta, GA 30332-0520 404-894-4395 http:// Dr. Charles W. Mulford, Director INVESCO Chair and Professor of Accounting charles.mulford@mgt.gatech.edu Sohel Surani Graduate

Más detalles

memoria anual annual report

memoria anual annual report 22 1 estados financieros financial accounts 23 24 1.1 Comentarios a los estados financieros Comments on the financial statements En el ejercicio 2017, la cifra de negocio ha ascendido a 26.165 miles de,

Más detalles

Decisiones Financieras El cash flow de la firma

Decisiones Financieras El cash flow de la firma Decisiones Financieras El cash flow de la firma Guillermo López Dumrauf Universidad del Cema Septiembre de 2001 dumrauf@mbox.servicenet.com.ar Para que se usan los estados financieros Comunicar a los acreedores

Más detalles

bvc Reports Consolidated and Separate Results at the First Quarter of 2018 (1Q18)

bvc Reports Consolidated and Separate Results at the First Quarter of 2018 (1Q18) RELEVANT INFORMATION BOLSA DE VALORES DE COLOMBIA S.A. 2 May 2018 Financial Situations of the Issuer bvc Reports Consolidated and Separate Results at the First Quarter of 2018 (1Q18) Consolidated revenue

Más detalles

annual report estados financieros finantial accounts

annual report estados financieros finantial accounts 1 anual 2013 memoria annual report estados financieros finantial accounts 23 24 1.1 Comentarios a los estados financieros Comments on the financial statesments En el ejercicio 2013 la Cifra de Negocios

Más detalles

TRADUCCIÓN AL ESPAÑOL DE LA TAXONOMÍA XBRL DEL International Accounting Standards Board

TRADUCCIÓN AL ESPAÑOL DE LA TAXONOMÍA XBRL DEL International Accounting Standards Board TRADUCCIÓN AL ESPAÑOL DE LA TAXONOMÍA XBRL DEL International Accounting Standards Board Primary Financial Statements, Financial Reporting for Commercial and Industrial Entities (Versión de 15 de noviembre

Más detalles

BANCO INVEX, S.A., INSTITUCION DE BANCA MULTIPLE, INVEX GRUPO FINANCIERO FIDEICOMISO /TRUST No. 581 "PATRIMONIO" INFORME/REPORT No. 2014-3 (BIS) Periodo / Period Fecha Inicio / Start Date 01-mar-14 Fecha

Más detalles

bvc reporta resultados consolidados e individuales al IV trimestre de 2017 (4Q17)

bvc reporta resultados consolidados e individuales al IV trimestre de 2017 (4Q17) INFORMACIÓN RELEVANTE BOLSA DE VALORES DE COLOMBIA S.A. 2 de Marzo de 2018 Situaciones Financieras del Emisor bvc reporta resultados consolidados e individuales al IV trimestre de 2017 (4Q17) Los Ingresos

Más detalles

Reduction of Income Tax monthly payments Mexico

Reduction of Income Tax monthly payments Mexico August 2017 Introduction When taxpayers estimate in a fiscal year (usually through estimates) That they are making Income Tax monthly payments excessively (when the total amount of monthly payments at

Más detalles

Cuadro 1 PRINCIPALES INDICADORES MACROECONÓMICOS MAIN ECONOMIC INDICATORS Proyección MMMR T 2T Primer Semestre MMMR 2012

Cuadro 1 PRINCIPALES INDICADORES MACROECONÓMICOS MAIN ECONOMIC INDICATORS Proyección MMMR T 2T Primer Semestre MMMR 2012 CUADROS ESTADÍSTICOS Fuente: INEI, BCRP, MEF. Fuente: INEI. Cuadro 1 PRINCIPALES INDICADORES MACROECONÓMICOS MAIN ECONOMIC INDICATORS 1T 2T Primer Semestre PRECIOS Y TIPO DE CAMBIO PRICES AND EXCHANGE

Más detalles

Quarterly Financial Information

Quarterly Financial Information Quarterly Financial Information [105000] Management commentary...2 [110000] General information about financial statements...8 [210000] Statement of financial position, current/non-current...9 [310000]

Más detalles

RESULTADOS DEL QIS 5 EN ESPAÑA

RESULTADOS DEL QIS 5 EN ESPAÑA RESULTADOS DEL QIS 5 EN ESPAÑA J u a n C a r l o s Ar a q u e L i é b a n a D i r e c c i ó n G e n e r a l d e S e g u r o s y F o n d o s d e P e n s i o n e s 23 de marzo de 2011 ANÁLISIS CUANTITATIVO

Más detalles

Indicadores para entidades Globalmente sistémicas

Indicadores para entidades Globalmente sistémicas 1 Indicadores para entidades Globalmente sistémicas Como parte de la respuesta de las autoridades regulatorias a la crisis financiera, en la reunión del G-20 de noviembre 2011 se aprobó establecer unos

Más detalles

Mejoras Operativas y una Atractiva Valuación Soportan la Recomendación de Compra

Mejoras Operativas y una Atractiva Valuación Soportan la Recomendación de Compra feb-14 mar-14 abr-14 may-14 jun-14 jul-14 ago-14 sep-14 oct-14 nov-14 dic-14 ene-15 COMPAÑIA MINERA AUTLAN, S.A.B. DE C. V. 17 de febrero 2015 Mejoras Operativas y una Atractiva Valuación Soportan la Recomendación

Más detalles

Adobe informa de que los resultados financieros del tercer trimestre han sido positivos

Adobe informa de que los resultados financieros del tercer trimestre han sido positivos Para mayor información contacte con: Mariló Hurtado en Brand Comunicación Telf. 932 700 909 Ref. nº: 487 Adobe informa de que los resultados financieros del tercer trimestre han sido positivos La empresa

Más detalles

BVC reporta resultados consolidados e individuales al III trimestre de 2017 (3Q17)

BVC reporta resultados consolidados e individuales al III trimestre de 2017 (3Q17) INFORMACIÓN RELEVANTE BOLSA DE VALORES DE COLOMBIA S.A. 2 de Noviembre de 2017 Situaciones Financieras del Emisor BVC reporta resultados consolidados e individuales al III trimestre de 2017 (3Q17) Los

Más detalles

AUTORITAT PORTUÀRIA DE BALEARS 2015 MEMORIA ANUAL

AUTORITAT PORTUÀRIA DE BALEARS 2015 MEMORIA ANUAL AUTORITAT PORTUÀRIA DE BALEARS 2015 MEMORIA ANUAL 1.1 CUENTA DE PÉRDIDAS Y GANANCIAS CORRESPONDIENTE AL EJERCICIO TERMINADO EL 31-12-15 PROFIT AND LOSS STATEMENT FOR THE YEAR ENDING 31-12-15 1.2 BALANCE

Más detalles

Madrid, a 20 de septiembre de 2004

Madrid, a 20 de septiembre de 2004 Madrid, a 20 de septiembre de 2004 COMISIÓN NACIONAL DEL MERCADO DE VALORES Paseo de la Castellana, 19 28046 Madrid Referencia: Resultados de Riviana Foods Inc. Muy señores nuestros: Por la presente les

Más detalles

BANCO INVEX, S.A., INSTITUCION DE BANCA MULTIPLE, INVEX GRUPO FINANCIERO FIDEICOMISO /TRUST No. 648 "PATRIMONIO" INFORME / REPORT No. 2013-5 Periodo / Period Fecha Inicio / Start Date 01-may-13 03-ene-00

Más detalles

Notas a los Estados Financieros (Cifras en millones de pesos) Estado de Posición Financiera

Notas a los Estados Financieros (Cifras en millones de pesos) Estado de Posición Financiera 64 Situación financiera Financl Situation Notas a los Estados Financieros (Cifras en millones de pesos) Estado de Posición Financiera Total del Activo: Presenta un saldo de $872.6, el cual fue inferior

Más detalles

Chile s experience in the improvement of the pension offer process

Chile s experience in the improvement of the pension offer process Chile s experience in the improvement of the pension offer process Sergio Baeza Chairman of the Board SCOMP S.A. July 2014 Pag : 1 Agenda 1 Situation prior to the change 2 Purpose of the reform 3 Model

Más detalles

Como Determinar la Viabilidad Económica de un Negocio

Como Determinar la Viabilidad Económica de un Negocio Como Determinar la Viabilidad Económica de un Negocio Presentado por: Marcus Sullivan, MBA, CVA Sullivan Consulting, Inc. 2013 Sullivan Consulting, Inc. 21 de marzo de 2013 Que es la Viabilidad Económica?

Más detalles

CREIGHTON ELEMENTARY SCHOOL DISTRICT NO. 14 BOND ELECTION NOVEMBER 8, 2016 PROPOSED CAPITAL IMPROVEMENTS

CREIGHTON ELEMENTARY SCHOOL DISTRICT NO. 14 BOND ELECTION NOVEMBER 8, 2016 PROPOSED CAPITAL IMPROVEMENTS CREIGHTON ELEMENTARY SCHOOL DISTRICT NO. 14 BOND ELECTION NOVEMBER 8, 2016 PROPOSED CAPITAL IMPROVEMENTS The following table presents the capital improvements expected to be paid from bond proceeds, the

Más detalles

ISSUERS WITH THE LARGER STOCK EXCHANGE CAPITALIZATION

ISSUERS WITH THE LARGER STOCK EXCHANGE CAPITALIZATION IN MILLIONS OF PESOS % Variation during the month % Variation during yhe year % Variation year to date IN DOLLARS % Variation during the month % Variation during the year % Variation year to date MARKET

Más detalles

BVC reports consolidated and stand alone results to the I Quarter 2017 (1Q17)

BVC reports consolidated and stand alone results to the I Quarter 2017 (1Q17) RELEVANT INFORMATION BOLSA DE VALORES DE COLOMBIA S.A. 5 May 2017 Financial Situation of the issuer BVC reports consolidated and stand alone results to the I Quarter 2017 (1Q17) Consolidated revenues reached

Más detalles

Short-Term Stock and Inventory Survey (ECSE). Base 2015 Third quarter of Provisional data

Short-Term Stock and Inventory Survey (ECSE). Base 2015 Third quarter of Provisional data 05 December 2018 (Text in translation process) Short-Term Stock and Inventory Survey (ECSE). Base 2015 Third quarter of 2018. Provisional data El índice del nivel de existencias de mercaderías en el Comercio

Más detalles

Interim Report Q3 2018

Interim Report Q3 2018 Interim Report Q3 2018 4 A KEY FIGURES Q3 Key Figures Group amounts in millions Q3 2018 Q3 2017 % change Revenue 40,211 40,745 2-1 1 Europe 16,151 16,682-3 thereof Germany 5,931 5,803 +2 NAFTA 11,743 11,525

Más detalles

Patrimonio, S.A. de C.V., SOFOM

Patrimonio, S.A. de C.V., SOFOM SALDOS CARTERA / PORT BAL Patrimonio, S.A. de C.V., SOFOM Reporte de aplicación de cobranza del 01 al 28 de Febrero de 2014 Fideicomiso 649 Pesos Beginning Balance Saldo Inicial de los Montos Diferidos

Más detalles

Consejería de Economía y Hacienda

Consejería de Economía y Hacienda DEUDA PÚBLICA ANOTADA BOLETÍN Nº 39 ABRIL 2003 Consejería de Economía y Hacienda SUMARIO/SUMMARY Las expectativas en torno al conflicto bélico en Irak y su posterior desarrollo han sido los dos factores

Más detalles

En enero se inscriben en los registros de la propiedad fincas, un 13,2% más que en el mismo mes del año anterior

En enero se inscriben en los registros de la propiedad fincas, un 13,2% más que en el mismo mes del año anterior 14 March 2018 (Text in translation process) Statistics on Transfer of Property Rights (STPR) January 2018. Provisional data En enero se inscriben en los registros de la propiedad 176.911 fincas, un 13,2%

Más detalles

Dic. Mar. Jun. Set. Dic. Mar. Jun. Jul. Ago. Set. Oct.

Dic. Mar. Jun. Set. Dic. Mar. Jun. Jul. Ago. Set. Oct. 2014 2015 2016 Dic. Mar. Jun. Set. Dic. Mar. Jun. Jul. Ago. Set. Oct. CUENTAS MONETARIAS DE LAS SOCIEDADES DE DEPÓSITO MONETARY ACCOUNTS OF THE DEPOSITORY CORPORATIONS (Millones de soles) table 1 / 2/

Más detalles

Quarterly Financial Information

Quarterly Financial Information Quarterly Financial Information [105000] Management commentary...2 [110000] General information about financial statements...8 [210000] Statement of financial position, current/non-current...10 [310000]

Más detalles

MEXICAN STOCK EXCHANGE

MEXICAN STOCK EXCHANGE STOCK EXCHANGE CODE: BALANCE SHEETS TO SEPTEMBER 3 OF 28 AND 27 (Mexican Pesos) QUARTER: 3 YEAR: 28 REF S CONCEPTS CURRENT YEAR PREVIOUS YEAR Amount Amount s1 TOTAL ASSETS 24,425,79 1 23,821,938 1 s2 s3

Más detalles

Quarterly Financial Information

Quarterly Financial Information Quarterly Financial Information [105000] Management commentary...2 [110000] General information about financial statements...8 [210000] Statement of financial position, current/non-current...10 [310000]

Más detalles

Quarterly Financial Information

Quarterly Financial Information Quarterly Financial Information [105000] Management commentary...2 [110000] General information about financial statements...9 [210000] Statement of financial position, current/non-current...10 [310000]

Más detalles

Presence in 4 continents with projects in 43 Countries. Collaborating with more than 50,000 PYMES

Presence in 4 continents with projects in 43 Countries. Collaborating with more than 50,000 PYMES Presence in 4 continents with projects in 43 Countries Collaborating with more than 50,000 PYMES 2015 Capex (Mex) - $8.1Bn USD Employees 306,788 New Jobs* 11,546 *(includes direct & indirect origination)

Más detalles

BANCO INVEX, S.A., INSTITUCION DE BANCA MULTIPLE, INVEX GRUPO FINANCIERO FIDEICOMISO /TRUST No. 581 "PATRIMONIO" INFORME/REPORT No. 2015-5 Periodo / Period Fecha Inicio / Start Date 01-may-15 Fecha Final

Más detalles

Sonae Sierra registra un beneficio neto de 58,9 millones de euros en la primera mitad de 2018

Sonae Sierra registra un beneficio neto de 58,9 millones de euros en la primera mitad de 2018 Sonae Sierra registra un beneficio neto de 58,9 millones de euros en la primera mitad de 2018 Maia Portugal, 10 de agosto, 2018 El beneficio directo aumenta un 9,3% hasta los 33 millones de euros El EBIT

Más detalles

The date of this call is April 23, 2013. Before we start, let me remind you that this call is property of Wal-Mart de México S.A.B. de C.V.

The date of this call is April 23, 2013. Before we start, let me remind you that this call is property of Wal-Mart de México S.A.B. de C.V. The date of this call is April 23, 2013. Before we start, let me remind you that this call is property of Wal-Mart de México S.A.B. de C.V. and is intended for the use of the company s shareholders and

Más detalles

Ada County Existing/Resale

Ada County Existing/Resale Ada County Existing/Resale October 2018 ket Statistics Report provided by Boise Regional REALTORS Data from the Intermountain MLS as of ember 11, 2018 Key Metrics Oct 2017 Oct 2018 % Chg YTD 2017 YTD 2018

Más detalles

Ada County Existing/Resale

Ada County Existing/Resale Ada County Existing/Resale tember 2018 ket Statistics Report provided by Boise Regional REALTORS Key Metrics 2017 2018 % Chg YTD 2017 YTD 2018 % Chg Closed Sales 811 616-24.0% 6,301 6,136-2.6% Median Sales

Más detalles

Proyecto para el Avalúo de Aprendizaje

Proyecto para el Avalúo de Aprendizaje Universidad de Puerto Rico en Aguadilla Departamento de Administración de Empresas Proyecto para el Avalúo de Aprendizaje Transacciones entre la empresa matriz home office y sus sucursales Preparado por:

Más detalles

Forus Earnings Results 1Q May 19th 2017

Forus Earnings Results 1Q May 19th 2017 Forus Earnings Results 1Q 2017 May 19th 2017 Index Agenda 1. Summary of Results 2. Highlights of the period 3. Financial Results 4. Q&A 2 Summary of Consolidated Results 1Q 2017 Net Profit of US$ 9.4 million

Más detalles

BANCO INVEX, S.A., INSTITUCION DE BANCA MULTIPLE, INVEX GRUPO FINANCIERO FIDEICOMISO /TRUST No. 581 "PATRIMONIO" INFORME/REPORT No.

BANCO INVEX, S.A., INSTITUCION DE BANCA MULTIPLE, INVEX GRUPO FINANCIERO FIDEICOMISO /TRUST No. 581 PATRIMONIO INFORME/REPORT No. BANCO INVEX, S.A., INSTITUCION DE BANCA MULTIPLE, INVEX GRUPO FINANCIERO FIDEICOMISO /TRUST No. 581 "PATRIMONIO" INFORME/REPORT No. 2008-3 Periodo / Period Fecha Inicio / Start Date 01-Mar-08 Fecha Final

Más detalles

GRUPO INTEGRAL DE ASESORIA FISCAL v' Y ADMINISTRATIVA, S.C.

GRUPO INTEGRAL DE ASESORIA FISCAL v' Y ADMINISTRATIVA, S.C. I.e GRUPO INTEGRAL DE ASESORIA FISCAL v' Y ADMINISTRATIVA, S.C. e;,- JOSE FRANCISCO CAMPOS RUIZ Certified Public Accountant e '. IPCA PHARMACEUTICALS LIMITED S.A. DE C.V. FINANCIAL STATEMENTS MARCH 31,

Más detalles

Georgia Tech Financial Analysis Lab 800 West Peachtree Street NW Atlanta, GA

Georgia Tech Financial Analysis Lab 800 West Peachtree Street NW Atlanta, GA 800 West Peachtree Street NW Atlanta, GA 30332-0520 404-894-4395 http:// Dr. Charles W. Mulford, Director INVESCO Chair and Professor of Accounting charles.mulford@mgt.gatech.edu Sohel Surani Graduate

Más detalles

RESULTADOS ENERO-DICIEMBRE 2009

RESULTADOS ENERO-DICIEMBRE 2009 RESULTADOS ENERO-DICIEMBRE 2009 31 de diciembre de 2009 - 1 - La información consolidada del Grupo Antena 3 adjunta ha sido preparada de acuerdo con lo establecido por las Normas Internacionales de Información

Más detalles